David Himmelstein

David U. Himmelstein is an American academic physician specializing in internal medicine. He is a distinguished professor of public health and health policy in the CUNY School of Public Health at Hunter College, an adjunct clinical professor at Albert Einstein College of Medicine, and a lecturer at Harvard Medical School. He is also the co-founder (with Steffie Woolhandler) of Physicians for a National Health Program, an organization advocating for single-payer healthcare in the United States.

Biography

Himmelstein received his M.D. from the Columbia University College of Physicians and Surgeons. He then completed his training at the University of California San Francisco's Highland Hospital and his fellowship at Harvard Medical School, both in internal medicine. He was formerly the chief of the division of social and community medicine at Cambridge Hospital in Massachusetts.[1]

Research

Himmelstein is the author or co-author of over 100 peer-reviewed articles on health care-related issues like medical bankruptcies and health care costs in the United States. For example, a 1984 study he published on patient dumping spurred the United States' Congress to pass the Emergency Medical Treatment and Active Labor Act, a law which banned the practice.[1] With Woolhandler, he has also researched the effect of uninsurance on mortality.[2][3]

gollark: Just autogenerate music.
gollark: That sounds worse.
gollark: Suuuuuure.
gollark: No. I don't like pop mostly.
gollark: No. My point was more that music celebrities™ are not generally known for sound philosophy.

References
  1. "Speakers Bureau". Physicians for a National Health Program. Retrieved 2017-07-24.
  2. Park, Madison (18 September 2009). "45,000 American deaths associated with lack of insurance". www.cnn.com. Retrieved 2017-07-24.
  3. Hamblin, James (30 June 2017). "A New Analysis Puts the Cost of the Senate Health Bill at 28,600 Lives Per Year". The Atlantic. Retrieved 2017-07-24.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.